Pioneering microfluidics technologies to treat pregnant populations
Wednesday, April 26, 2023

A research group at the University of Manitoba is using microfluidics technologies from Dolomite Microfluidics to design and evaluate novel nanoparticle drug delivery systems for the safe and effective treatment of diseases during pregnancy. The laboratory has developed an innovative microfluidic... .. read more..

Blacktrace launches Particle Works – the new dedicated particle engineering b...
Thursday, April 7, 2022

  Blacktrace Holdings Ltd – a world leader in Productizing Science® – is excited to announce the launch of Particle Works, a spin out of Dolomite Microfluidics. The official launch of this new brand will take place at the LNP Formulation and Process Development Summit in Boston, MA, from the... .. read more..

Microfluidics offers easier and faster manufacturing of nanomedicines
Wednesday, June 30, 2021

  Researchers at Queen’s University Belfast are using microfluidics to fabricate particles for the encapsulation of drugs and biologics for imaging, treatment and cell targeting. Dr Dimitrios Lamprou, a Reader in Pharmaceutical Engineering at the School of Pharmacy, explained: “Our wor... .. read more..

Dolomite Microfluidics and Phosphorex partner to accelerate lipid nanoparticl...
Tuesday, June 1, 2021

  Dolomite Microfluidics, a leading developer of particle systems for drug delivery, and Phosphorex, Inc., a leading contract development and manufacturing organization specializing in particle-based formulation of drug products, are pleased to announce their partnership to establish unique ... .. read more..

Dolomite Microfluidics launches Automated Nanoparticle System for formulation...
Tuesday, March 23, 2021

    Dolomite Microfluidics is leading the way in nanoparticle production with the release of its innovative Automated Nanoparticle (ANP) System for microfluidic formulation library generation This next generation automated platform is the result of a four-year focus on the challenges co... .. read more..

Dolomite aids the development of artificial intelligence for microfluidics
Thursday, January 14, 2021

    Microfluidic technologies are rapidly becoming the method of choice for micro- and nanoparticle production across a number of sectors, from cell biology research to drug development. This approach offers a number of advantages over traditional batch methods, including precise proces... .. read more..

Dolomite celebrates 15 years of microfluidic innovation
Thursday, December 3, 2020

  We’re celebrating 15 years of excellence in the design and manufacture of novel, high-quality microfluidic products and solutions!   Dolomite was the world’s first microfluidic application centre and has gone through extraordinary and continuous growth since its formation in 2005, mov... .. read more..

Enhancing interferometry with Dolomite’s Mitos Dropix
Tuesday, November 24, 2020

    Researchers at Vanderbilt University have developed a novel interferometry approach – the compensated interferometry reader (CIR) – and are using Dolomite’s Mitos Dropix to provide reproducible droplet production. Interferometers are widely used in science and industry for the measu... .. read more..

New Dolomite Microfluidics and MilliporeSigma collaboration
Tuesday, November 10, 2020

  Dolomite Microfluidics and MilliporeSigma collaborate to release off-the-shelf microfluidic device kits for the fabrication of PLGA particles   Dolomite Microfluidics and MilliporeSigma have partnered to create a range of off-the-shelf NanoFabTx™ microfluidic device kits for the pro... .. read more..

Inside Dolomite Labs: Double Emulsions for FACS
Tuesday, November 3, 2020

    Novel biopharmaceutical development forms an integral part of the fast-growing medicine and biologics market. Whilst targeted biologic therapies such as enzymes, monoclonal antibodies and many more show specificity and promise in the treatment of cancer and other diseases, they lack... .. read more..

Powered by Feed Informer